Ramadan Fasting Presents Unique Diabetes Management Challenges Says Presenter at American Association of Clinical Endocrinologists Congress

Thursday, May 4, 2017 3:15 pm EDT

Dateline:

AUSTIN, Texas

AUSTIN, Texas--(BUSINESS WIRE)--While cultural considerations are part and parcel of optimal diabetes care around the world, there is one group in particular whose disease management requires special attention, cautioned an endocrinologist presenting at today at the American Association of Clinical Endocrinologists 26th Annual Scientific and Clinical Congress.

Citing statistics from the CREED study in his presentation “Personalized Diabetes Management: Cultural Considerations,” Dr. Osama Hamdy, Director of the Inpatient Diabetes Program at Joslin Diabetes Center, noted that 94.2 percent of Muslims with diabetes fasted for at least half of the month during the holy month of Ramadan and two-thirds fasted every day.

The time frame for Ramadan fasting, which includes no foods or fluids, begins at sunrise following Suhūr (the meal consumed pre-dawn) and concludes at sunset with Iftar, the meal served at the end of the day. Summer fasting periods can last up to 20 hours per day and are often undertaken in hot and humid conditions, which can further exacerbate risks associated with the fasting, which can include hypoglycemia, hyperglycemia, dehydration and thrombosis, and diabetic ketoacidosis.

Dr. Hamdy suggested that pre-Ramadan diabetes education is necessary to avoid complications in those who insist on fasting and should focus on six areas: risk quantification; blood glucose monitoring; fluids and dietary advice; exercise advice; adjusting treatment regimens; and when to break the fast. Trial fasting is also recommended to detect hypoglycemia or hyperglycemia risk.

He further noted that very few patients with type 2 diabetes who were on insulin could safely fast during Ramadan and thus will need adjustments of their insulin doses and/or timings to allow for a greater number of fasting days without acute complications.

Dr. Hamdy will discuss highlights of his presentation during a press briefing on Thursday, May 4, at 12:30 p.m. at the AACE 26th Annual Scientific and Clinical Congress.

About the American Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 7,000 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. A majority of AACE members are certified in endocrinology, diabetes and metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our site at www.aace.com.

About the American College of Endocrinology (ACE)

The American College of Endocrinology (ACE) is the educational and scientific arm of the American Association of Clinical Endocrinologists (AACE). ACE is the leader in advancing the care and prevention of endocrine and metabolic disorders by: providing professional education and reliable public health information; recognizing excellence in education, research and service; promoting clinical research and defining the future of Clinical Endocrinology. For more information, please visit www.aace.com/college.

Contact:

American Association of Clinical Endocrinologists
Mary Green, 407-506-2960
mgreen@aace.com